de Feyter P J, Serruys P W, Brower R W, van den Brand M, ten Katen H J, Hugenholtz P G, Bos E
Am J Cardiol. 1985 Feb 1;55(4):362-6. doi: 10.1016/0002-9149(85)90376-5.
During a follow-up period of 3 years, among a consecutive series of 423 patients who gave informed consent for recatheterization both 1 and 3 years after coronary artery bypass grafting, the incidence of severely symptomatic patients with New York Heart Association class III or IV was 19% (79 of 423). The predictive value of approximately 80 clinical, angiographic and perioperative variables was too low to be of clinical value. Adverse clinical outcome was associated with a high closure rate of the grafts. Forty-six percent of the patients could not undergo reoperation because of unsuitable coronary anatomy. With intensive medical therapy half of these patients improved to functional class I or II, while of those patients who were reoperable 32% improved to class I or II with intensive pharmacologic treatment instead of reoperation. The nonresponders underwent reoperation, which resulted in improvement of symptoms to functional class I or II in most (83%).
在3年的随访期内,在连续423例冠状动脉搭桥术后1年和3年均签署再次导管插入术知情同意书的患者中,纽约心脏协会III或IV级严重症状患者的发生率为19%(423例中的79例)。约80个临床、血管造影和围手术期变量的预测价值过低,无临床价值。不良临床结局与移植血管的高闭合率相关。46%的患者因冠状动脉解剖结构不合适而无法再次手术。通过强化药物治疗,这些患者中有一半改善为I或II级功能状态,而在那些可再次手术的患者中,32%通过强化药物治疗而非再次手术改善为I或II级。无反应者接受了再次手术,大多数(83%)患者的症状改善为I或II级功能状态。